+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells



Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells



Oncotarget 6(42): 44688-44702



Photodynamic therapy (PDT) not only kills tumor cells directly but also rapidly recruits and activates immune cells favoring the development of antitumor adaptive immunity. It is believed that Topical 5-aminolevulinic acid mediated photodynamic therapy (ALA-PDT) can induce anti-tumor immune responses through dangerous signals damage-associated molecular patterns (DAMPs). In this study, we investigated the effect of ALA-PDT induced DAMPs on immune cells. We focused on the stimulation of dendritic cells by major DAMPs, enhanced the expression of calreticulin (CRT), heat shock proteins 70 (HSP70), and high mobility group box 1 (HMGB1), either individually or in combination. We evaluated in vitro and in vivo expressions of DAMPs induced by ALA-PDT using immunohistochemistry, western blot, and ELISA in a squamous cell carcinoma (SCC) mouse model. The role of DAMPs in the maturation of DCs potentiated by ALA-PDT-treated tumor cells was detected by FACS and ELISA. Our results showed that ALA-PDT enhanced the expression of CRT, HSP70, and HMGB1. These induced DAMPs played an important part in activating DCs by PDT-treated tumor cells, including phenotypic maturation (increase of surface expression of MHC-II, CD80, and CD86) and functional maturation (enhanced capability to secrete IFN-γ and IL-12). Furthermore, injecting ALA-PDT-treated tumor cells into naïve mice resulted in complete protection against cancer cells of the same origin. Our findings indicate that ALA-PDT can increase DAMPs and enhance tumor immunogenicity, providing a promising strategy for inducing a systemic anticancer immune response.

(PDF emailed within 1 workday: $29.90)

Accession: 058905914

Download citation: RISBibTeXText

PMID: 26625309


Related references

Stimulation of maturation and antigen presenting activity of dendritic cells by vesiculated alpha-tocopheryl succinate-treated tumor cells. 2007

Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7. Journal of Cancer Research and Clinical Oncology 129(9): 511-520, 2003

IL-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumor cells. Journal of Dermatological Science 16(SUPPL 1): S7, 1998

Induction of anti-tumor activity in T cells of ovarian cancer patients after ex vivo stimulation by dendritic cells pulsed with autologous apoptotic tumor. Gynecologic Oncology 80(2): 309-310, 2001

Tumor rejection induced by dendritic cells co-injected with tumor cells treated with anti-cancer drug. International Journal of Cancer Supplement (13): 155, 2002

Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93(5): 1634-1642, 1999

Dendritic cells coinjected with tumor cells treated with an anticancer drug to induce tumor rejection. Surgery Today 33(4): 269-276, 2003

Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with dendritic cells loaded with tumor cells. Onkologie 23(Sonderheft 7): 175, 2000

Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells. International Journal of Cancer 91(6): 749-756, 15 March, 2001

Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses. Clinical and Experimental Immunology 151(2): 284-296, 2007

Calcium ionophore and cytokine treatment of human peripheral blood myeloid cells produces dendritic cells with an enhanced ability to sensitize autologous CD8+ T cells to tumor antigens in a single culture stimulation. Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 631, 1997

Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation. Oncoimmunology 2(8): E25375, 2013

Maturation and migration of dendritic cells upon stimulation with heat-killed tumor cells. Animal Cells and Systems 16(3): 215-223, 2012